Free Trial

10 Best Small Cap Stocks to Buy Now - 7 of 10

 
 

Oruka Therapeutics (NASDAQ:ORKA)

Consensus Rating
Buy
Rating Score
3.3
Ratings Breakdown
7 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$42.00 (61.5% Upside)

About Oruka Therapeutics

Oruka Therapeutics logoARCA biopharma, Inc, a biopharmaceutical company, develops genetically-targeted therapies for heart failure and cardiovascular diseases. It is positioned to bring personalized therapies for the treatment of cardiovascular disease, through the use of genetics. Complementing the Company's cardiovascular science, ARCA's management team has significant experience in developing and commercializing cardiovascular products. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
10/7/2024HC WainwrightInitiated CoverageBuy$45.00
9/17/2024Leerink PartnrsUpgradeStrong-Buy
9/17/2024Leerink PartnersInitiated CoverageOutperform$44.00
9/16/2024Lifesci CapitalInitiated CoverageOutperform$41.00
9/16/2024TD CowenInitiated CoverageBuy
9/13/2024Jefferies Financial GroupInitiated CoverageBuy$40.00
9/4/2024WedbushInitiated CoverageOutperform$40.00
9/3/2024WedbushUpgradeStrong-Buy
 

50-Yr Wall Street Legend: “Sell this AI stock NOW” (Ad)

Nearly 1 million people around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And in the aftermath of the biggest tech selloff since 2022...

He just gave them an urgent SELL alert for one beloved AI stock.